Bausch + Lomb Corporation

NYSE:BLCO

Medical - Instruments & Supplies

Healthcare
$20.95 +0.27%

+$0.04 today

Market cap
$7.49B
Beta
0.57
P/E (TTM)
-24.2
EPS (TTM)
-$0.62
52W Low $11.58High $18.92

Volume 0.51M

Average 0.46M

BLCO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Bausch + Lomb CorporationNYSE: BLCO

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 357.1M shares rose 1.0% year over year, in line with the +0.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +0.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.0% holds above the trailing-twelve-month pace of +0.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
357.1M+0.5% QoQ
Last fiscal yearDec 2025
353.8M+0.6% YoY
LTMJun 2026
355.23M+0.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year+0.6%——
3-year CAGR+0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
353.8M USD
Year-over-year change
+0.6%
4-year CAGR
+0.3%

Weighted Avg Shares vs competitors

How BLCO compares with its peers on the latest reported figures

  • BLCO's LTM Jun 2026 weighted avg shares of 355.23M shares is the highest of the 10 companies compared; the peer median is 94.81M shares.
  • Its year-over-year change of +0.8% is the 8th highest of 10, against a peer median of +5.6%.
  • Over three fiscal years its annual growth of +0.4% compares with a peer median of +5.0%.
BLCO Competitors Peer median
Weighted Avg Shares for BLCO and competitors
Company Period LTM YoY 3-year CAGR
BLCOBausch + Lomb CorporationLTM Jun 2026355.23M +0.8%+0.4%
OSCROscar Health, Inc.LTM Jun 2026285.73M +15.7%+7.3%
TGTXTG Therapeutics, Inc.LTM Sep 2026142.49M -2.4%+2.1%
ARWRArrowhead Pharmaceuticals, Inc.LTM Sep 2026141.87M +6.5%+9.9%
PCVXVaxcyte, Inc.LTM Jun 2026139.07M +7.3%+28.0%
CRSPCRISPR Therapeutics AGLTM Sep 202694.81M +8.4%+5.0%
PTCTPTC Therapeutics, Inc.LTM Jun 202681.93M +5.6%+3.5%
MMSIMerit Medical Systems, Inc.LTM Sep 202659.58M +1.1%+1.4%
GKOSGlaukos CorporationLTM Jun 202657.84M +3.1%+6.4%
TFXTeleflex IncorporatedLTM Jun 202644.07M -4.5%-1.6%
Peer median (excluding BLCO) 94.81M+5.6%+5.0%

Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.77B3.77B4.15B4.79B5.1B
Cost of Revenue1.47B1.52B1.64B1.87B2.31B
Gross Profit2.3B2.25B2.5B2.92B2.79B
Gross Margin61.0%59.7%60.4%60.9%54.8%
Research & Development271M307M324M343M371M
Selling, General & Admin1.39B1.48B1.74B2.08B2.23B
Operating Expenses1.97B2.04B2.37B2.76B2.61B
Depreciation & Amortization415M379M382M436M421M
EBITDA733M598M499M601M535M
EBITDA Margin19.5%15.9%12.0%12.5%10.5%
Operating Income329M207M130M162M188M
Operating Margin8.7%5.5%3.1%3.4%3.7%
Interest Income06M15M15M12M
Interest Expense0146M283M399M431M
Other Income / Expenses(11M)(134M)(296M)(396M)(505M)
Income Before Tax318M73M(166M)(234M)(317M)
Pre-Tax Margin8.4%1.9%-4.0%-4.9%-6.2%
Income Tax Expense125M58M82M71M35M
Net Income182M6M(260M)(317M)(360M)
Net Margin4.8%0.2%-6.3%-6.6%-7.1%
EPS (Basic)0.520.04(0.74)(0.90)(1.02)
EPS (Diluted)0.520.04(0.74)(0.90)(1.02)
Weighted Avg Shares350M350M350.5M351.8M353.8M
Weighted Avg Shares (Diluted)350M350M350.5M351.8M353.8M

Bausch + Lomb Corporation

NYSE:BLCO

Intrinsic Alpha fair value

Locked

Current Price

$20.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.